FDCDDQ
TARO

Federation des caisses Desjardins du Quebec’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15
Closed -$436 – 2406
2022
Q4 		$436 Hold
15
– – ﹤0.01% 2364
2022
Q3 		$450 Buy
+15
New +$517 ﹤0.01% 2407
2019
Q2 		– Sell
-500
Closed -$54K – 2344
2019
Q1 		$54K Buy
+500
New +$49.8K ﹤0.01% 1305
2018
Q1 		– Sell
-150
Closed -$15.7K – 2231
2017
Q4 		$15.7K Hold
150
– – ﹤0.01% 1618
2017
Q3 		$16.9K Hold
150
– – ﹤0.01% 1563
2017
Q2 		$16.8K Hold
150
– – ﹤0.01% 1615
2017
Q1 		$17.5K Buy
+150
New +$16.6K ﹤0.01% 1317

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TARO Position: Q1 2023 in Review

Federation des caisses Desjardins du Quebec sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2023, closing a stake of 15 shares — an estimated $436 sold.

Federation des caisses Desjardins du Quebec first reported a position in TARO in Q1 2017 and held it in 7 quarters. The position peaked at $54K in Q1 2019. 62 funds tracked by Wall St. Rank hold TARO as of Q1 2023.

  • Federation des caisses Desjardins du Quebec reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2023 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 15 Taro Pharmaceutical Industries Ltd. shares in Q1 2023, an estimated $436.
  • Federation des caisses Desjardins du Quebec first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2017 and held it in 7 quarters.
  • Federation des caisses Desjardins du Quebec's Taro Pharmaceutical Industries Ltd. position peaked at $54K in Q1 2019.
  • 62 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2023.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2023, filed 15 Aug 2024.